Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. A new multiplex RT-qPCR method for the simultaneous detection and discrimination of Zika and chikungunya viruses.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
   Article
2. Sloths host Anhanga virus-related phleboviruses across large distances in time and space.Transboundary and emerging diseases · 2020
   Article
3. What Does the Future Hold for Yellow Fever Virus? (II).Genes · 2018
   Review
4. Nucleoside analogs to manage sequence divergence in nucleic acid amplification and SNP detection.Nucleic acids research · 2018
   Article
5. Efficient and unbiased metagenomic recovery of RNA virus genomes from human plasma samples.Scientific reports · 2017
   Article
6. Assay optimization for molecular detection of Zika virus.Bulletin of the World Health Organization · 2016
   Article
7. A robust HIV-1 viral load detection assay optimized for Indian sub type C specific strains and resource limiting setting.Biological research · 2014
   Article
8. Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains.Journal of clinical microbiology · 2013
   Article
9. Performance of the novel Qiagen artus QS-RGQ viral load assays compared to that of the Abbott RealTime system with genetically diversified HIV and hepatitis C Virus plasma specimens.Journal of clinical microbiology · 2012
   Article
10. Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.Virology journal · 2011
    Article
11. An avoidable transmission of HIV from mother to child.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2011
    Article
12. Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China.Molecular diagnosis & therapy · 2010
    Article
13. Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay.Journal of clinical microbiology · 2009
    Article
14. Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants.Journal of clinical microbiology · 2008
    Article
15. Development and validation of a vero cell-based suspension method for the detection of Zika virus.Revista peruana de medicina experimental y salud publica
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

8 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as